SMS Pharma.
Drug Manufacturers - General · SMSPHARMA
Small CapHealthcareMature Stable
Ramesh Babu Potluri
Chairman and Managing Director · Pragmatic
Company DNA
Founder-Centric
About
SMS Pharma. is a Small Cap company in the Healthcare sector, listed on NSE as SMSPHARMA. With a market cap of ₹4K Cr and revenue of ₹779 Cr, it is currently in the Mature Stable phase. Known for its Founder-Centric culture and Fast-Follower approach to innovation, the company operates at a Steady-Marathon pace. Family-promoted entity with 75% promoter holding; long-term leadership stability under the CMD. Its strategic mandate: Given the strict global regulatory environment for API manufacturers, the company requires leadership focused on quality compliance and risk mitigation.
FAQ
What kind of company is SMS Pharma.?
SMS Pharma. is a Small Cap Healthcare company (SMSPHARMA) in the Mature Stable phase with a market cap of ₹4K Cr. It is classified as Founder-Centric in culture.
What is SMS Pharma.'s culture and work environment like?
SMS Pharma. has a Founder-Centric culture with Fast-Follower innovation DNA and a Steady-Marathon pace of execution. Employee brand: Steady Employer. Customer relationship style: B2B-Enterprise. Family-promoted entity with 75% promoter holding; long-term leadership stability under the CMD.
Who leads SMS Pharma.?
SMS Pharma. is led by Ramesh Babu Potluri (Chairman and Managing Director), a Pragmatic leader with 42 years of experience.
What are SMS Pharma.'s financials?
SMS Pharma. reported revenue of ₹779 Cr in FY25 with a 5-year revenue CAGR of 14.8%. Operating margin: 13.4%. Market cap: ₹4K Cr.
Culture & Strategy
CultureFounder-Centric
InnovationFast-Follower
PaceSteady-Marathon
PurposeProfit-Pure
CustomerB2B-Enterprise
EmployeeSteady Employer
BrandTechnical-Expert
LifecycleMature Stable
Family-promoted entity with 75% promoter holding; long-term leadership stability under the CMD.
Mandate
Given the strict global regulatory environment for API manufacturers, the company requires leadership focused on quality compliance and risk mitigation.
Given the strict global regulatory environment for API manufacturers, the company requires leadership focused on quality compliance and risk mitigation.
Financials
Revenue FY25₹779 Cr
PAT FY25₹69 Cr
Rev CAGR 5Y14.8%
OPM13.4%
NPM8.9%
ROE10.8%
ROCE12.6%
P/E36.8
Fwd P/E—
P/B4.5
D/E44.5
Mkt Cap₹4K Cr
Promoter75%
Institutional3.2%
Similar Culture
Could You Lead SMS Pharma.?
Take the Genome Benchmark →